(Read More: How to Trade Bernanke's Comments)
CME closed at $76.45 per share, down 25 cents.
Marcin's other pick for a rising-rate environment was Zoetis, which closed at $31.04 per share, up 6 cents.
The best stock picks don't necessarily pay a dividend, she added, noting that such was the case withAIG, one of the largest holdings in her Gabelli Dividend Income Fund.
"It's total return, but we find that companies that can pay a cash dividend and do, usually have more confidence in the cash portion of their earnings and the growth of their earnings," she said.
Marcin characterized how the stock market was filtering Fed Chairman Ben Bernanke's comments, which were supportive of continued asset buying.
(Read More: Bernanke: Highly Accommodative Policy Needed for 'Foreseeable Future')
"Certainly the market right now seems to be saying, 'OK, we thought we thought we heard the end of the buying programs by year and exiting totally by 2014, and maybe we're not hearing that now.' So, maybe that's the reaction, but I think that the genie's out of the interest-rate bottle and I think that we're in it for a period of rising rates," she said.
Traderdisclosure: On July 10, 2013, the following stocks and commodities mentioned orintended to be mentioned on CNBC's "Fast Money" were owned by the "Fast Money"traders: Dan Nathan is short BBRY Jan 12/10 call spread; Dan Nathan is long TLTJuly 110/115/120 call spread; Dan Nathan is long FB July/Aug 25 put spread; DanNathan is long XLF July 19/18 put spread; Dan Nathan is long ZNGA; Dan Nathanis long Aug 100/95/90 put fly; Karen Finerman is long AAPL; Karen Finerman islong BAC; Karen Finerman is long C; Karen Finerman is long JPM; Karen Finermanis long TGT; Karen Finerman is long GOOG; Karen Finerman is long GM; KarenFinerman is long M; Karen Finerman is long SPY; Karen Finerman is long MDY PUTS;Guy Adami is long C; Guy Adami is long GS; Guy Adami is long INTC; Guy Adami islong MSFT; Guy Adami is long AGU; Guy Adami is long NUE; Guy Adami is long BTU;Guy Adami's wife, Linda Snow, works at Merck.